Multi-Gene Assay Predicts Recurrence In Newly Diagnosed Breast Cancer
FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds
Surgery Without Radiation Found Inadequate for DCIS
QOL With Femara Comparable To Placebo, Analysis Finds
EMEND Improved Emesis In Men And Women, Trials Find
Biopsies Could Be Reduced By Computer-Aided-Detection
Chemo+Radiation Preserves Voice, RTOG Study Finds
Low-Dose IFN Not Effective Against Melanoma, Study Finds
NeoPharm To Begin Phase III Trial For Glioblastoma
Elderly Men Say Physicians Are Recommending PSA Tests
NCI-Approved Protocols Listed
Trending Stories
- Class action complaint alleging GRAIL insider fraud resubmitted after dismissal
- Cancer centers adapt to life without site visits as NIH changes CCSG review
- How GLP-1RA drugs are reshaping patient physiology and the future of oncology
- Friends publishes three white papers ahead of annual meeting
Topics: Clinical trials on rare cancers, combination drug trials, multi-regional studies - Jonathan Licht named president, chief scientific officer at Van Andel Institute
- Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA









